Skip to main navigation Skip to search Skip to main content

Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting

Press/Media: Press / Media

PeriodApr 25 2022

Media coverage

1

Media coverage

  • TitleAvadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date4/25/22
    PersonsAsim Roy
View all 1
View less